Hematological, hepatic, and retinal phenotypes in mice deficient for prolyl hydroxylase domain proteins in the liver

American Journal of Pathology

Volumn 184, Issue 4, 2014, Pages 1240-1250

  Duan, Li Juan ^a   Takeda, Kotaro ^a   Fong, Guo Hua ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROLYL HYDROXYLASE DOMAIN PROTEIN 1; PROLYL HYDROXYLASE DOMAIN PROTEIN 2; PROLYL HYDROXYLASE DOMAIN PROTEIN 3; UNCLASSIFIED DRUG;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY FAILURE; CONGENITAL BLOOD VESSEL MALFORMATION; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; ENZYME DEFICIENCY; ERYTHROPOIESIS; FATTY LIVER; HEMATOCRIT; LIPID LIVER LEVEL; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; ANIMAL; DEFICIENCY; DISEASE MODEL; ENZYMOLOGY; KNOCKOUT MOUSE; LIVER; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RETINA DISEASE; WESTERN BLOTTING;

ANEMIA; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; KIDNEY FAILURE, CHRONIC; LIVER; MICE; MICE, KNOCKOUT; PROLYL HYDROXYLASES; REAL-TIME POLYMERASE CHAIN REACTION; RETINAL DISEASES;

EID: 84897845235     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.12.014     Document Type: Article

References (41)

1. A.C. Epstein, J.M. Gleadle, L.A. McNeill, K.S. Hewitson, J. O'Rourke, D.R. Mole, M. Mukherji, E. Metzen, M.I. Wilson, A. Dhanda, Y.M. Tian, N. Masson, D.L. Hamilton, P. Jaakkola, R. Barstead, J. Hodgkin, P.H. Maxwell, C.W. Pugh, C.J. Schofield, and P.J. Ratcliffe C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation Cell 107 2001 43 54
2. R.K. Bruick, and S.L. McKnight A conserved family of prolyl-4- hydroxylases that modify HIF Science 294 2001 1337 1340
3. M. Ivan, T. Haberberger, D.C. Gervasi, K.S. Michelson, V. Günzler, K. Kondo, H. Yang, I. Sorokina, R.C. Conaway, J.W. Conaway, and W.G. Kaelin Jr. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor Proc Natl Acad Sci USA 99 2002 13459 13464
4. P.H. Maxwell, M.S. Wiesener, G.W. Chang, S.C. Clifford, E.C. Vaux, M.E. Cockman, C.C. Wykoff, C.W. Pugh, E.R. Maher, and P.J. Ratcliffe The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature 399 1999 271 275
5. K. Takeda, V.C. Ho, H. Takeda, L.J. Duan, A. Nagy, and G.H. Fong Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2 Mol Cell Biol 26 2006 8336 8346
6. K. Takeda, A. Cowan, and G.H. Fong Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system Circulation 116 2007 774 781
7. M. Mazzone, D. Dettori, R. Leite de Oliveira, S. Loges, T. Schmidt, B. Jonckx, Y.M. Tian, A.A. Lanahan, P. Pollard, C. Ruiz de Almodovar, F. De Smet, S. Vinckier, J. Aragonés, K. Debackere, A. Luttun, S. Wyns, B. Jordan, A. Pisacane, B. Gallez, M.G. Lampugnani, E. Dejana, M. Simons, P. Ratcliffe, P. Maxwell, and P. Carmeliet Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization Cell 136 2009 839 851
8. K. Takeda, H.L. Aguila, N.S. Parikh, X. Li, K. Lamothe, L.J. Duan, H. Takeda, F.S. Lee, and G.H. Fong Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins Blood 111 2008 3229 3235
9. Y.A. Minamishima, J. Moslehi, N. Bardeesy, D. Cullen, R.T. Bronson, and W.G. Kaelin Jr. Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure Blood 111 2008 3236 3244
10. M.J. Percy, P.W. Furlow, P.A. Beer, T.R. Lappin, M.F. McMullin, and F.S. Lee A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove Blood 110 2007 2193 2196
11. M. Hölscher, M. Silter, S. Krull, M. von Ahlen, A. Hesse, P. Schwartz, B. Wielockx, G. Breier, D.M. Katschinski, and A. Zieseniss Cardiomyocyte-specific prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injury J Biol Chem 286 2011 11185 11194
12. J. Moslehi, Y.A. Minamishima, J. Shi, D. Neuberg, D.M. Charytan, R.F. Padera, S. Signoretti, R. Liao, and W.G. Kaelin Jr. Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathy Circulation 122 2010 1004 1016
13. J. Hyvärinen, I.E. Hassinen, R. Sormunen, J.M. Mäki, K.I. Kivirikko, P. Koivunen, and J. Myllyharju Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury J Biol Chem 285 2010 13646 13657
14. A. Ginouvès, K. Ilc, N. Macías, J. Pouysségur, and E. Berra PHDs overactivation during chronic hypoxia "desensitizes" HIFalpha and protects cells from necrosis Proc Natl Acad Sci USA 105 2008 4745 4750
15. J. Aragonés, M. Schneider, K. Van Geyte, P. Fraisl, T. Dresselaers, and M. Mazzone et al. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism Nat Genet 40 2008 170 180
16. J. Rius, M. Guma, C. Schachtrup, K. Akassoglou, A.S. Zinkernagel, V. Nizet, R.S. Johnson, G.G. Haddad, and M. Karin NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha Nature 453 2008 807 811
17. E.P. Cummins, E. Berra, K.M. Comerford, A. Ginouves, K.T. Fitzgerald, F. Seeballuck, C. Godson, J.E. Nielsen, P. Moynagh, J. Pouyssegur, and C.T. Taylor Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity Proc Natl Acad Sci USA 103 2006 18154 18159
18. Y. Takeda, S. Costa, E. Delamarre, C. Roncal, R. Leite de Oliveira, M.L. Squadrito, V. Finisguerra, S. Deschoemaeker, F. Bruyère, M. Wenes, A. Hamm, J. Serneels, J. Magat, T. Bhattacharyya, A. Anisimov, B.F. Jordan, K. Alitalo, P. Maxwell, B. Gallez, Z.W. Zhuang, Y. Saito, M. Simons, M. De Palma, and M. Mazzone Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis Nature 479 2011 122 126
19. W. Jelkmann Molecular biology of erythropoietin Intern Med 43 2004 649 659
20. P. Koivunen, P. Tiainen, J. Hyvärinen, K.E. Williams, R. Sormunen, S.J. Klaus, K.I. Kivirikko, and J. Myllyharju An endoplasmic reticulum transmembrane prolyl 4-hydroxylase is induced by hypoxia and acts on hypoxia-inducible factor alpha J Biol Chem 282 2007 30544 30552
21. A. Laitala, E. Aro, G. Walkinshaw, J.M. Mäki, M. Rossi, M. Heikkilä, E.R. Savolainen, M. Arend, K.I. Kivirikko, P. Koivunen, and J. Myllyharju Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis Blood 120 2012 3336 3344
22. M. Nangaku Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure J Am Soc Nephrol 17 2006 17 25
23. V.H. Haase, J.N. Glickman, M. Socolovsky, and R. Jaenisch Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor Proc Natl Acad Sci USA 98 2001 1583 1588
24. E.B. Rankin, M.P. Biju, Q. Liu, T.L. Unger, J. Rha, R.S. Johnson, M.C. Simon, B. Keith, and V.H. Haase Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo J Clin Invest 117 2007 1068 1077
25. P.P. Kapitsinou, Q. Liu, T.L. Unger, J. Rha, O. Davidoff, B. Keith, J.A. Epstein, S.L. Moores, C.L. Erickson-Miller, and V.H. Haase Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia Blood 116 2010 3039 3048
26. M. Scortegagna, K. Ding, Q. Zhang, Y. Oktay, M.J. Bennett, M. Bennett, J.M. Shelton, J.A. Richardson, O. Moe, and J.A. Garcia HIF-2alpha regulates murine hematopoietic development in an erythropoietin-dependent manner Blood 105 2005 3133 3140
27. Y.A. Minamishima, and W.G. Kaelin Jr. Reactivation of hepatic EPO synthesis in mice after PHD loss Science 329 2010 407
28. W. Querbes, R.L. Bogorad, J. Moslehi, J. Wong, A.Y. Chan, E. Bulgakova, S. Kuchimanchi, A. Akinc, K. Fitzgerald, V. Koteliansky, and W.G. Kaelin Jr. Treatment of erythropoietin deficiency in mice with systemically administered siRNA Blood 120 2012 1916 1922
29. T. Yokozawa, P.D. Zheng, H. Oura, and F. Koizumi Animal model of adenine-induced chronic renal failure in rats Nephron 44 1986 230 234
30. K. Ataka, H. Maruyama, T. Neichi, J. Miyazaki, and F. Gejyo Effects of erythropoietin-gene electrotransfer in rats with adenine-induced renal failure Am J Nephrol 23 2003 315 323
31. Y. Oyama, T. Hashiguchi, N. Taniguchi, S. Tancharoen, T. Uchimura, K.K. Biswas, K. Kawahara, T. Nitanda, Y. Umekita, M. Lotz, and I. Maruyama High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy Lab Invest 90 2010 853 866
32. T. Tanaka, K. Doi, R. Maeda-Mamiya, K. Negishi, D. Portilla, T. Sugaya, T. Fujita, and E. Noiri Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury Am J Pathol 174 2009 1203 1211
33. C. Postic, M. Shiota, K.D. Niswender, T.L. Jetton, Y. Chen, J.M. Moates, K.D. Shelton, J. Lindner, A.D. Cherrington, and M.A. Magnuson Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase J Biol Chem 274 1999 305 315
34. L.E. Smith, E. Wesolowski, A. McLellan, S.K. Kostyk, R. D'Amato, R. Sullivan, and P.A. D'Amore Oxygen-induced retinopathy in the mouse Invest Ophthalmol Vis Sci 35 1994 101 111
35. E.A. Pierce, R.L. Avery, E.D. Foley, L.P. Aiello, and L.E. Smith Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization Proc Natl Acad Sci USA 92 1995 905 909
36. K.M. Connor, N.M. Krah, R.J. Dennison, C.M. Aderman, J. Chen, K.I. Guerin, P. Sapieha, A. Stahl, K.L. Willett, and L.E. Smith Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis Nat Protoc 4 2009 1565 1573
37. N.L. Tomasic, L. Piterkova, C. Huff, E. Bilic, D. Yoon, G.Y. Miasnikova, A.I. Sergueeva, X. Niu, S. Nekhai, V. Gordeuk, and J.T. Prchal The phenotype of polycythemia due to Croatian homozygous VHL (571C>G:H191D) mutation is different from that of Chuvash polycythemia (VHL 598C>T:R200W) Haematologica 98 2013 560 567
38. S. Perrotta, D.P. Stiehl, F. Punzo, S. Scianguetta, A. Borriello, D. Bencivenga, M. Casale, B. Nobili, S. Fasoli, A. Balduzzi, L. Cro, K.J. Nytko, R.H. Wenger, and F. Della Ragione Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range Haematologica 98 2013 1624 1632
39. L. Lanikova, F. Lorenzo, C. Yang, H. Vankayalapati, R. Drachtman, V. Divoky, and J.T. Prchal Novel homozygous VHL mutation in exon 2 is associated with congenital polycythemia but not with cancer Blood 121 2013 3918 3924
40. J. Chen, K.M. Connor, C.M. Aderman, and L.E. Smith Erythropoietin deficiency decreases vascular stability in mice J Clin Invest 118 2008 526 533
41. J.E. Sears, G. Hoppe, Q. Ebrahem, and B. Anand-Apte Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy Proc Natl Acad Sci USA 105 2008 19898 19903